Laura Simon Treml
Corporate Officer/Principal en ARATANA THERAPEUTICS INC .
Cargos activos de Laura Simon Treml
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ARATANA THERAPEUTICS INC | Corporate Officer/Principal | 26/03/2013 | - |
Historial de carrera de Laura Simon Treml
Formación de Laura Simon Treml.
| University of Pennsylvania | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 3 |
Operativa
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 2 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Aratana Therapeutics, Inc.
 Aratana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aratana Therapeutics, Inc. engages in the development and commercialization of pet therapeutics. Its portfolio includes NOCITA, ENTYCE, and GALLIPRANT. NOCITA (bupivacaine liposome injectable suspension) acts as a local post-operative analgesia for cranial cruciate ligament surgery in dogs, and as a peripheral nerve block to provide regional post-operative analgesia following onychectomy in cats. ENTYCE(capromorelin oral solution) is intended for appetite stimulation in dogs. GALLIPRANT (grapiprant tablets) is for the control of pain and inflammation associated with osteoarthritis in dogs. The company was founded by Linda Rhodes and Steven St. Peter on December 1, 2010 and is headquartered in Leawood, KS. | Health Technology |
- Bolsa de valores
- Insiders
- Laura Simon Treml
- Experiencia
